The Preclinical Development of Medisorb® Naltrexone, a Once a Month Long-Acting Injection, for the Treatment of Alcohol Dependence

Frontiers in Bioscience - Landmark - United States
doi 10.2741/1559
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Frontiers in Bioscience

Related search

Treatment-Completion Rates With Olanzapine Long-Acting Injection Versus Risperidone Long-Acting Injection in a 12-Month, Open-Label Treatment of Schizophrenia: Indirect, Exploratory Comparisons

International Journal of General Medicine
Medicine
2012English

A Critical Appraisal of Paliperidone Long-Acting Injection in the Treatment of Schizoaffective Disorder

Therapeutics and Clinical Risk Management
2016English

The Efficacy of Acamprosate and Naltrexone in the Treatment of Alcohol Dependence, Europe Versus the Rest of the World: A Meta-Analysis

Addiction
MedicinePsychiatryMental Health
2015English

V0162 a New Long-Acting Bronchodilator for Treatment of Chronic Obstructive Lung Diseases: Preclinical and Clinical Results

Respiratory Research
PulmonaryRespiratory Medicine
2015English

Efficacy of Acamprosate for the Treatment of Alcohol Dependence Long After Recovery From Withdrawal Syndrome

Journal of Clinical Psychiatry
MedicinePsychiatryMental Health
2015English

Acamprosate: A Prototypic Neuromodulator in the Treatment of Alcohol Dependence

CNS and Neurological Disorders - Drug Targets
MedicineNeurosciencePharmacology
2010English

Nalmefene: A New Approach to the Treatment of Alcohol Dependence

Substance Abuse and Rehabilitation
2014English

Treatment of Alcohol Dependence

Liver Transplantation
HepatologyTransplantationSurgery
1997English

Disulfiram Efficacy in the Treatment of Alcohol Dependence: A Meta-Analysis

PLoS ONE
Multidisciplinary
2014English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy